Advertisement

Folia Microbiologica

, 52:375 | Cite as

Ribotyping and biotyping ofStaphylococcus epidermidis isolated from hospital environment

  • L. Malíková
  • I. Sedláček
  • D. Nováková
  • M. Němec
Article

Abstract

TheStaphylococcus strains acquired from scrapings from hospital environments were identified to the species level based on their biochemical properties. From the monitored sample theStaphylococcus epidermidis strains were selected for more accurate typing and tested on their virulence factor and ribotyped. The biotyping ofS. epidermidis did not show any considerable intraspecific variation of these isolates and there were no atypical reactions, with the exception of three strains (out of 33). In contrast, the results of ribotyping showed greater heterogeneity of strains and unequivocally demonstrated the relation between the ribotype and the place of sample drawing. In addition to this fact, the found ribotypes repeat in the same environment in the long term which suggests the occurrence and persistence of the same strains of conditionally pathogenic bacteria in hospital environment. We showed that ribotyping is a suitable method for precise and reliable detection of some coagulase-negative staphylococci.

Keywords

Linezolid Acetoin Hospital Environment Novobiocin Furazolidon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

CCM

Czech Collection of Microorganisms

CCTS

Centre of Cardiovascular and Transplantation Surgery

CoNS

coagulase-negative staphylococci

MMCH

Masaryk Memorial Cancer Hospital

NRL

National Reference Laboratory

TH

Traumatological Hospital

References

  1. Bingen E.H., Denamur E., Elion J.: Use of ribotyping in epidemiological surveillance of nosocomial outbreaks.Clin.Microbiol.Rev. 7, 311–327 (1991).Google Scholar
  2. Christensen G.D., Barker L.P., Mawhinney T.P.: Identification of an antigenic marker of slime production forStaphylococcus epidermidis.Infect.Imun. 58, 2906–2911 (1990).Google Scholar
  3. Drozenová J., Petráš P.: Properties of coagulase-negative staphylococci isolated from hemocultures. (In Czech)Epidemiol.Mikrobiol.Imunol. 49, 51–58 (2000).PubMedGoogle Scholar
  4. Geary C., Jordens J.Z., Richardson J.F., Hawcroft D.M., Mitchell C.J.: Epidemiological typing of coagulase-negative staphylococci from nosocomial infection.J.Med.Microbiol. 46, 195–203 (1997).PubMedCrossRefGoogle Scholar
  5. Hebert G.A., Cooksey R.C., Clark N.C., Hill B.C., Jarvis W.R., Thornsberry C.: Biotyping coagulase-negative staphylococci.J.Clin.Microbiol. 26, 1950–1956 (1988).PubMedGoogle Scholar
  6. Huebner J., Goldmann D.A.: Coagulase-negative staphylococci: role as pathogens.Ann.Rev.Med. 50, 223–236 (1999).PubMedCrossRefGoogle Scholar
  7. Izard N.C., Hachler H., Grehn M., Kayser F.H.: Ribotyping of coagulase-negative staphylococci with special emphasis on intraspecific typing ofStaphylococcus epidermidis.J.Clin.Microbiol. 30, 817–823 (1992).PubMedGoogle Scholar
  8. Kloos W.E.: Taxonomy of systematics of staphylococci indigenous to human, pp. 113–137 inThe Staphylococci in Human and Disease (K.B. Crossley, G.L. Archer, Eds). Churchill Livingstone, New York 1997.Google Scholar
  9. Kloos W.E., Bannerman T.L.: Update of clinical significance of coagulase-negative staphylococci.Clin.Microbiol.Rev. 7, 117–140 (1994).PubMedGoogle Scholar
  10. Kubešová J., Petráš P.: Coagulase-negative staphylococci isolated from hemocultures (In Czech)Scripta Med. 69, 52–53 (1996).Google Scholar
  11. Nováková D., Sedláček I., Pantůček R., Štětina V., Švec P., Petráš P.:Staphylococcus equorum andStaphylococcus succinus isolated from human clinical specimens.J.Med.Microbiol. 55, 523–528 (2006).PubMedCrossRefGoogle Scholar
  12. Schaberg D.R., Culver D.H., Gaynes R.P.: Major trends in the microbial etiology of nosocomial infection.Am.J.Med. 91, 72–75 (1991).CrossRefGoogle Scholar
  13. Walencka E., Sadowska B., Różalska S., Hryniewicz W., Różalska B.:Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.Folia Microbiol. 51, 381–386 (2006).CrossRefGoogle Scholar

Copyright information

© Institute of Microbiology, Academy of Sciences of the Czech Republic 2007

Authors and Affiliations

  • L. Malíková
    • 1
  • I. Sedláček
    • 2
  • D. Nováková
    • 2
  • M. Němec
    • 3
  1. 1.Regional Public Health InstituteBrnoCzechia
  2. 2.Czech Collection of Microorganisms, Faculty of ScienceMasaryk UniversityBrnoCzechia
  3. 3.Department of Microbiology, Faculty of ScienceMasaryk UniversityBrnoCzechia

Personalised recommendations